Publicação científica trimestral do CREMERJ - número 4 - 2022

30 Lúpus Eritematoso Sistêmico: o que o clínico precisa saber Mirhelen Mendes de Abreu Med. Ciên. e Arte , Rio de Janeiro, v.1, n.4, p.13-30, out-dez 2022 16. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29:288-91. 17. Jesus D, Matos A, Henriques C, et al. Derivation and validation of the SLE disease activity score (SLE- DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Ann Rheum Dis 2019; 78:365-71. 18. Fanouriakis A, et al. Update ο n the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 2021; 80:14-25. 19. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019; 78:736-45. 20. Kostopoulou M, Nikolopoulos D, Parodis I, et al. Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention. Curr Vasc Pharmacol 2020; 18:549-65. 21. Tselios K, Gladman DD, Su J, et al. Impact of the newherpes esthiomenos. American College of Cardiology/ American heart association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis 2020; 79:612-7. 22. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol 2018; 71: e127-248. 23. Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 2017; 76:2009-16.